Literature DB >> 17048075

Thymus development in Macaca fascicularis (Cynomolgus monkey): an approach for toxicology and embryology.

Eberhard Buse1, Gunnar Habermann, Friedhelm Vogel.   

Abstract

Thymus development was studied in the cynomolgus monkey from day 35 of gestation (gd 35) to the stage of advanced involution in a 21-year-old monkey. Special emphasis was placed on thymus cell generation and cellular pattern formation. At gd 35, the epithelial bud of the thymus was visible in a sagittal position at the level of the thoracic aperture. At gd 50, first lymphocyte-like cells and few Human Leukocyte Antigen-D Region (HLA-DR) immunoreactive cells appeared. The cortico-medullary differentiation, Hassall's body precursors and faint immunoreactivity for T-lymphocytes (CD 3-positive) were detected from gd 60 onwards. First macrophages (CD 68 positive) were apparent at day 70, first CD 20 immunoreactive cells (B-lymphocyte-like cells) at gd 85, and natural killer cells (M1014 immunoreactive) at gd 100. At gd 100 all evaluated cell populations present in the adult cynomolgus monkey thymus were in place, whereas no B- and T-cell precursors or (CD 34 and CD 117, respectively) dendritic cells (CD 35 positive cells) were present. All these immunopositive cells persisted, partly with changing distribution patterns, until the advanced age of 21 years with the exception of natural killer cells, which were present only until adult ages (evaluation at 4-7 years). The rationale of this study was to analyse thymic development in the cynomolgus monkey and to evaluate the relevance of the development of thymus in non-human primate as a model for corresponding human targeted toxicological research.

Entities:  

Mesh:

Year:  2006        PMID: 17048075     DOI: 10.1007/s10735-006-9057-2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  27 in total

Review 1.  Nonclinical evaluation of therapeutic cytokines: immunotoxicologic issues.

Authors:  Peter T Thomas
Journal:  Toxicology       Date:  2002-05-15       Impact factor: 4.221

2.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 3.  Early events in T-cell maturation.

Authors:  B Adkins; C Mueller; C Y Okada; R A Reichert; I L Weissman; G J Spangrude
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

4.  Murine embryonic B lymphocyte development in the placenta.

Authors:  F Melchers
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

Review 5.  The development of the human thymus microenvironment.

Authors:  B von Gaudecker
Journal:  Curr Top Pathol       Date:  1986

6.  Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes.

Authors:  H Galkowska; L O Waldemar; U Wojewodzka
Journal:  Vet Immunol Immunopathol       Date:  1996-10       Impact factor: 2.046

7.  Flow cytometric analysis of normal B lymphoid development.

Authors:  M R Loken; V O Shah; Z Hollander; C I Civin
Journal:  Pathol Immunopathol Res       Date:  1988

8.  Monoclonal antibody (anti-Leu 7) directed against natural killer cells reacts with normal, benign and malignant prostate tissues.

Authors:  Z A Wahab; G L Wright
Journal:  Int J Cancer       Date:  1985-12-15       Impact factor: 7.396

9.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  The role of the thymus in development of immunologic capacity in rabbits and mice.

Authors:  R A GOOD; A P DALMASSO; C MARTINEZ; O K ARCHER; J C PIERCE; B W PAPERMASTER
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.